[PDF] Top 20 A meta-analysis of ABCG2 gene polymorphism and non-small cell lung cancer outcomes
Has 10000 "A meta-analysis of ABCG2 gene polymorphism and non-small cell lung cancer outcomes" found on our website. Below are the top 20 most common "A meta-analysis of ABCG2 gene polymorphism and non-small cell lung cancer outcomes".
A meta-analysis of ABCG2 gene polymorphism and non-small cell lung cancer outcomes
... between ABCG2 gene polymorphisms of 34 GG/(GA + AA) loci, 421 CC/(AC + AA) loci, and non-small cell lung cancer (NSCLC) therapeutic effects via ...PubMed ... See full document
6
Lymphangiogenic Markers and Their Impact on Nodal Metastasis and Survival in Non-Small Cell Lung Cancer--A Structured Review with Meta-Analysis.
... availability of small-molecule inhibitors and antibodies that could potentially target tumor lymphangiogenesis it seems appropriate that this treatment should be offered patients to whom it may prove ... See full document
17
Economic outcomes of maintenance gefitinib for locally advanced/metastatic non-small-cell lung cancer with unknown EGFR mutations: a semi-Markov model analysis.
... impact of maintenance gefitinib treatment versus placebo after 4 chemotherapeutic cycles of first-line platinum-based chemotherapy for patients with locally ad- vanced/metastatic NSCLC [22], on the basis ... See full document
9
Pemetrexed plus platinum as the first-line treatment option for advanced non-small cell lung cancer: a meta-analysis of randomized controlled trials.
... search of PubMed, EMBASE and CENTRAL (the Cochrane Central Register of Controlled Trials) database was performed in December 2011, using the following key words as the search terms: ‘‘NSCLC’’, ... See full document
8
Whole brain radiotherapy plus concurrent chemotherapy in non-small cell lung cancer patients with brain metastases: a meta-analysis.
... 40% of patients with cancer develop brain metastases (BM) during their disease ...as lung and, breast cancer or melanoma, are at high risk for ...50% of primary lung ... See full document
6
Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.
... Subgroup analysis is a method for exploring the sources of heterogeneity and for increasing the reliability of an ...prognosis of NSCLC [39]. While the patients in the included studies ... See full document
13
Single-agent maintenance therapy for advanced non-small cell lung cancer (NSCLC): a systematic review and Bayesian network meta-analysis of 26 randomized controlled trials
... treatment and are candidates for systemic therapy only, with a dismal 5-year survival rate of <5% (Rossi et ...evolution of individualized systemic treatment for advanced ...development of ... See full document
24
CYP1A1 Ile462Val polymorphism contributes to lung cancer susceptibility among lung squamous carcinoma and smokers: a meta-analysis.
... year of publication, ethnicity, total numbers of cases and controls, and numbers of cases and controls who harbored the Ile462Val (exon 7) genotypes, ...author of the ... See full document
11
Serum levels of the cancer-testis antigen POTEE and its clinical significance in non-small-cell lung cancer.
... type of protein that is expressed in normal adult tissue only in the testis as well as a variety of tumors of different histological ...view of their pattern of expression and ... See full document
10
MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines.
... visualized and normalized using Gene- spring GX ...percentile of all measurements for that ...Because of the limitation of the resources, the statistic p-value may not be applicable ... See full document
9
Identification of novel deregulated RNA metabolism-related genes in non-small cell lung cancer.
... three of the eight up-regulated genes belong to the family of spliceosomal small nuclear ribonucleopro- teins (snRNPs): ASCC3L1, SNRPB, and ...complex of snRNPs plus a multitude ... See full document
12
Chemotherapy plus best supportive care versus best supportive care in patients with non-small cell lung cancer: a meta-analysis of randomized controlled trials.
... Lung cancer is the leading cause of cancer death worldwide for both men and ...one and a half million new cases are diagnosed each ...85% of all lung cancer ... See full document
9
Quantification of cell-free mSHOX2 Plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patients.
... Mandel and Metais were the first to describe their observation of the presence of extracellu- lar nucleic acids in humans ...in cell-free nucleic acids isolated from all different body fluids ... See full document
10
Association of TERT Polymorphisms with Clinical Outcome of Non-Small Cell Lung Cancer Patients.
... is of great importance for genome integrity and plays a crucial role in cancer initia- tion and ...TERT gene as risk factors for many cancer types ...studies of TERT ... See full document
13
Comparative outcome assessment of epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of advanced non-small-cell lung cancer: A network meta-analysis
... results of LUX-Lung 7 [27], a phase 2b trial comparing afatinib with gefitinib as first-line treatment in patients harboring EGFR mutations, that showed improvement in PFS and ORR with afatinib over ... See full document
11
BRCA1: a novel prognostic factor in resected non-small-cell lung cancer.
... values and ranges were derived for quantitative variables and mRNA gene ...means of absolute frequencies and ...among gene expression ...mRNA gene- expression levels as ... See full document
7
Polymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapy.
... SNPs of HR genetic polymorphisms ...T241M and NBN E185Q) to be associated with various types of cancer risks, including cancers of the lung, breast, ovary, leukemia and ... See full document
9
Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysis.
... most of the studies, arterial and venous invasion has not been separately studied pathologically due to the inability in some cases to discriminate between arterial and venous ...most of the ... See full document
8
Polymorphisms in XPD gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients: a meta-analysis of 24 studies.
... modification of NER pathway may have impact on tumor sensitivity to platinum based chemotherapy, and conse- quently influence clinical outcome and patient survival ...ERCC2) gene encodes for ... See full document
11
The prognostic value of phosphorylated AKT expression in non-small cell lung cancer: a meta-analysis.
... survival of cancer cells in breast, prostate, ovary, and brain tissue ...survival of NSCLC cell [29]. Recently, a clinical study of p-AKT expression in tissue from patients with ... See full document
6
temas relacionados